☆ 4.7 Editorial Material

Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic

DRUG DISCOVERY TODAY (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Biochemistry & Molecular Biology

Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic

Fabio Arena et al.

Summary: Genetic variability of the virus may impact the reliability of diagnostic protocols, but most virus variants currently have minimal impact on the sensitivity of existing diagnostic protocols. However, to address the continuous emergence of new variants, protocols including multiple targets should be preferred in the future.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Letter Medical Informatics

A Time of Optimism: Targeted Immunotherapeutics as the Long-Awaited Armamentaria Against the Scourge of Human Diseases

Charles Oo et al.

THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2020)

添加到收藏夹

Review Oncology

Repurposing anticancer drugs for the management of COVID-19

Khalid El Bairi et al.

EUROPEAN JOURNAL OF CANCER (2020)

添加到收藏夹

Editorial Material Biotechnology & Applied Microbiology

COVID-19 must catalyse changes to clinical development

Rod MacKenzie et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

添加到收藏夹

Review Oncology

Master protocols in clinical trials: a universal Swiss Army knife?

Thomas Sudhop et al.

LANCET ONCOLOGY (2019)

添加到收藏夹

Meeting Abstract Hematology

Patient-Reported Outcome Labeling for Malignant Hematology Drugs Approved in the United States: 2011-2017

Marjorie E. Zettler et al.

BLOOD (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Novel trial design: A report from the 19th Frontiers Symposium of ACCP

Barbara Ameer

JOURNAL OF CLINICAL PHARMACOLOGY (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.